Delic Holdings Corp. · OTC:DELCF
Delic — Investor Presentation (December 2022)
20 slides from Delic's investor presentation, December 2022
Slide 1: Expanding always. In all ways.
Expanding always. In all ways. (CSE: DELIC) & (OTCQB: DELCF)
Slide 2: Disclaimer
You Must Read This Before Continuing DISCLAIMER This corporate presentation (“Presentation”) is confidential and contains proprietary non-public information regarding Delic Corp (“Delic”, the “Company”, “we”, “us” or “our”). This Presentation is for information purposes only and does not constitute
Slide 3: Overview
OVERVIEW Delic Corp is a leader in new medicines and treatments for a modern world, improving access to health benefits across the country and reframing the conversation on psychedelics. We own the largest, profitable chain of wellness clinics in the U.S., operating 13 locations across nine states,
Slide 4: Problem
PROBLEM Mental health problems are Current popular There’s no scalable, widespread and getting worse, pharmaceutical treatments trusted network of psychedelic aren’t working for most. clinics with a repeatable, particularly after Covid-19. 63% of Americans who have non-habit forming and effective us
Slide 5: Solution
SOLUTION Psychedelic treatments have Ketamine has a 70% response The largest chain of trusted & been shown to have high rate in treatment resistant accessible patient clinics that depression as soon as 24h. accept insurance with high profit efficacy, and low side effects. margins and repeatable effe
Slide 6: Ecosystem: Media, Clinics, Labs
ECOSYSTEM MEDIA CLINICS LABS Meet Delic Ketamine Wellness Delic Labs The Largest Psychedelic Centers Licensed Cannabis & Wellness Event Ketamine Clinic Psilocybin Research Lab Reality Sandwich Digital Lifestyle Magazine 6
Slide 7: Market Potential
MARKET POTENTIAL ~32M people in the US have used psychedelics at least once 65% of Americans with anxiety, depression, PTSD say psychedelic medicine should be available for treatment-resistant conditions* $500B annual US spend on prescription drugs $238B annual US spend on mental health treatments &
Slide 8: Business Model
BUSINESS MODEL Delic Corp owns the largest chain of psychedelic wellness clinics in the country and a scalable ecosystem to increase revenue, profit margins and patient base. CLINIC FINANCIALS | CASE STUDY Open a Clinic Cost $250,000 USD Break even in ~6 months $1M USD at ~25-30% Average Clinic Reve
Slide 9: Patient Outcomes
Patient Outcomes effectiveness Random – bipolar sample size n=120 depression Response to effectiveness - Ketamine Treatment major depressive disorders of Depressive Disorders effectiveness - depression with PTSD/Anxiety Response defined by the Beck Depression Inventory-II (BDI-II) where a >35% reduc
Slide 10: Media | Audience Nurturing
MEDIA | AUDIENCE NURTURING CORP Tapping into cultural conversations through Delic-owned media properties and events featuring leading experts, thought leaders and advocates to: • Drive patients to the clinics for treatment • Remove stigma around these new medicines • Discuss what a healthy level of
Slide 11: Science | IP, R&D, Proven Products
SCIENCE | IP, R&D, Proven Products = We develop novel psychedelic products for markets that allow for legal psychedelics and treatment. Rooted in science and evidence-based research that informs all product lines and ensures innovative treatments are safe and of the highest quali- ty. Delic Labs has
Slide 12: Health | Clinic Services & Retail
HEALTH | Clinic Services & Retail The U.S.’s largest retail and physical footprint of ketamine clinics will allow us to scale patient access and increase average spends. Open Now Coming Soon • Phoenix, AZ • San Antonio, TX • Tuscon, AZ • Tampa Bay, FL • Mesa-Gilbert, AZ • Orlando, FL • Denver, CO •
Slide 13: Acquisition Strategy
ACQUISITION STRATEGY Delic has some of the most experienced and successful operators of ketamine clinics in-house. Rather than acquiring overvalued assets or attempting to rejuvenate underperforming operations, we believe our proven real estate, hiring, training, operations and treatment approach wi
Slide 14: Team
TEAM Our team is comprised of proven leaders, executors and free thinkers. Strong industry networks, profitable businesses and successful prior exits ensure we are best positioned to capitalize on the burgeoning psychedelic wellness industry. OPERATIONS KEVIN NICHOLSON MATHEW LEE DR. MARKUS ROGGEN C
Slide 15: Team: Advisors
TEAM ADVISORS SHEP GORDON DR. DAVE RABIN BARBARA BRANAMAN NY TIMES FILM AGENT & CIO & ED & BOARD CEO & VP OF MARKETING VP/GM of PRODUCER CO-FOUNDER CO-FOUNDER MEMBER FOUNDER & PRODUCT HOSTING KYLE SNOOK GARYN ANGEL MICHAEL LOVITCH DAVID BELSKY THINK MB ANGEL & ASSOCIATES SENIOR INFANTRY COO OFFICER
Slide 16: Competitor Comparison
COMPETITOR COMPARISON Quarterly Open U.S. Locations in Companies Ticker Business Model Geography Valuations Revenue Locations Development Delic Corp CSE:DELC Clinics, media USA $25M* N/A 13 15 *upon conversion of multiple voting shares Canada, USA, Field Trip Health TSX:FTRP Clinics, drug developmen
Slide 17: Timeline
TIMELINE DELIC CORP FIRST DELIC REALITY SANDWICH PUBLIC LISTING ACQUIRED CBDV / KWC ACQUISITION RAISE FOUNDED $ RAISE ACQUIRED ON CSE DELIC LABS ANNOUNCED 2nd ROUND September 2018 October 2018 June 2019 November 2020 June 2021 September 2021 September 2021 LAUNCH OF VA PARTNERSHIP LAUNCH OF CLINIC O
Slide 18: Cap Table
CAP TABLE Capital Structure Market Cap $2.4M Basic Shares Outstanding 83,777,623 52 Week Low $0.02 Fully Diluted Shares Outstanding 133,894,820 52 Week High $0.15 Management and Director Ownership 30% 0.1250 0.1000 0.0750 0.0500 54.71k 2022 Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 18
Slide 19: Why Invest Now?
WHY INVEST NOW? • Built largest, most profitable business model for scaling care directly to pa- tients, with 13 open locations today that accept insurance and more in the next 18 months, increasing spend per visitor, positioned as face of industry. • Current run rate of $9M USD, recently received $
Slide 20: Contact
CONTACT Rich Rodriguez 602.807.1889 rich@deliccorp.com 20